Literature DB >> 9846831

Kinetics of anaphylatoxin C5a receptor expression during experimental allergic encephalomyelitis.

S Nataf1, N Davoust, S R Barnum.   

Abstract

In this study, we investigated the expression of the C5aR in spinal cords of Lewis rats with experimental allergic encephalomyelitis (EAE). Using in situ hybridization (ISH) we analyzed the kinetics of C5aR at different time points of EAE (preclinical stage, clinical peak, remission phase). We observed that C5aR mRNA was readily detected in the CNS of EAE rats at all the stages of the disease. Using a combination of ISH and immunohistochemistry, we formally demonstrated that C5aR is strongly expressed on microglial cells and hypertrophic astrocytes during EAE. The potential involvement of C5a receptor in EAE physiopathology is discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9846831     DOI: 10.1016/s0165-5728(98)00169-6

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

Review 1.  Complement in neuroprotection and neurodegeneration.

Authors:  Vijay Yanamadala; Robert M Friedlander
Journal:  Trends Mol Med       Date:  2010-01-28       Impact factor: 11.951

Review 2.  Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease.

Authors:  S R Barnum
Journal:  Mol Med       Date:  1999-09       Impact factor: 6.354

Review 3.  Physiology of Astroglia.

Authors:  Alexei Verkhratsky; Maiken Nedergaard
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

4.  Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer's disease.

Authors:  Rahasson R Ager; Maria I Fonseca; Shu-Hui Chu; Sam D Sanderson; Stephen M Taylor; Trent M Woodruff; Andrea J Tenner
Journal:  J Neurochem       Date:  2010-02-02       Impact factor: 5.372

5.  Complement C5 in experimental autoimmune encephalomyelitis (EAE) facilitates remyelination and prevents gliosis.

Authors:  Susanna H Weerth; Horea Rus; Moon L Shin; Cedric S Raine
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

Review 6.  Complement in multiple sclerosis: its role in disease and potential as a biomarker.

Authors:  G Ingram; S Hakobyan; N P Robertson; B P Morgan
Journal:  Clin Exp Immunol       Date:  2008-11-24       Impact factor: 4.330

7.  The role of the complement system and the activation fragment C5a in the central nervous system.

Authors:  Trent M Woodruff; Rahasson R Ager; Andrea J Tenner; Peter G Noakes; Stephen M Taylor
Journal:  Neuromolecular Med       Date:  2009-09-11       Impact factor: 3.843

8.  IFN-gamma and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC-T cell complement production.

Authors:  Jinbo Liu; Feng Lin; Michael G Strainic; Fengqi An; Robert H Miller; Cengiz Z Altuntas; Peter S Heeger; Vincent K Tuohy; M Edward Medof
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

9.  Blockade of the C5a receptor fails to protect against experimental autoimmune encephalomyelitis in rats.

Authors:  B P Morgan; M Griffiths; H Khanom; S M Taylor; J W Neal
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.